BRPI0719111A8 - agente para inibir a sinalização de citocinina - Google Patents

agente para inibir a sinalização de citocinina

Info

Publication number
BRPI0719111A8
BRPI0719111A8 BRPI0719111A BRPI0719111A BRPI0719111A8 BR PI0719111 A8 BRPI0719111 A8 BR PI0719111A8 BR PI0719111 A BRPI0719111 A BR PI0719111A BR PI0719111 A BRPI0719111 A BR PI0719111A BR PI0719111 A8 BRPI0719111 A8 BR PI0719111A8
Authority
BR
Brazil
Prior art keywords
plant
growth
chemical
receptor
intracellular signaling
Prior art date
Application number
BRPI0719111A
Other languages
English (en)
Inventor
Nagasawa Asako
Uneme Hideki
Arata Yuto
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2007022850A external-priority patent/JP5082474B2/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of BRPI0719111A2 publication Critical patent/BRPI0719111A2/pt
Publication of BRPI0719111A8 publication Critical patent/BRPI0719111A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01G—HORTICULTURE; CULTIVATION OF VEGETABLES, FLOWERS, RICE, FRUIT, VINES, HOPS OR SEAWEED; FORESTRY; WATERING
    • A01G7/00—Botany in general
    • A01G7/06—Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N61/00—Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5097—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving plant cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Dentistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Ecology (AREA)
  • Forests & Forestry (AREA)
  • Biophysics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cultivation Of Plants (AREA)

Abstract

agente para inibir a sinalização de citocinina, reguladores de crescimento da planta, métodos para pesquisar uma substância química capaz de prom0- ver o crescimento de uma raiz de uma planta e de regulamento de crescimento da planta, e composto a presente invenção refere-se a uma substância que tem uma atividade de inibir a sinalização intracelular de um receptor de citocinina derivado da planta e que pode controlar o crescimento ou diferenciação de uma planta. descreve-se também um método para pesquisar uma substância química capaz de promover o crescimento de uma raiz de uma planta, que compreende medir o nível de sinalização intracelular do receptor em um sistema onde uma célula tendo o receptor é contatada com uma substância química tendo uma atividade agonística no receptor e uma substância a ser testada, comparar o nível de sinalização intracelular medido na etapa anterior com um nível de sinalização intracelular medido na ausência da substância química, e determinar a substância química como sendo uma substância química capaz de promover o crescimento de uma raiz de uma planta com base na diferença obtida pela comparação; e outros.
BRPI0719111A 2006-11-22 2007-11-22 agente para inibir a sinalização de citocinina BRPI0719111A8 (pt)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP2006-315309 2006-11-22
JP2006315309 2006-11-22
JP2006315308 2006-11-22
JP2006-315308 2006-11-22
JP2007022849 2007-02-01
JP2007-022849 2007-02-01
JP2007-022850 2007-02-01
JP2007022850A JP5082474B2 (ja) 2006-11-22 2007-02-01 新規なキナゾリン誘導体
PCT/JP2007/073126 WO2008062907A1 (fr) 2006-11-22 2007-11-22 Substance capable d'inhiber la signalisation de la cytokinine

Publications (2)

Publication Number Publication Date
BRPI0719111A2 BRPI0719111A2 (pt) 2013-12-10
BRPI0719111A8 true BRPI0719111A8 (pt) 2019-01-15

Family

ID=40863157

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0719111A BRPI0719111A8 (pt) 2006-11-22 2007-11-22 agente para inibir a sinalização de citocinina

Country Status (10)

Country Link
US (1) US8722580B2 (pt)
EP (1) EP2100507B1 (pt)
KR (2) KR20140054433A (pt)
CN (1) CN101588716B (pt)
BR (1) BRPI0719111A8 (pt)
CA (1) CA2669275C (pt)
ES (1) ES2532277T3 (pt)
PL (1) PL2100507T3 (pt)
RU (1) RU2477046C2 (pt)
WO (1) WO2008062907A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020123395A1 (en) 2018-12-10 2020-06-18 Ideaya Biosciences, Inc. 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors
WO2021252680A1 (en) * 2020-06-10 2021-12-16 Ideaya Biosciences, Inc. 4-arylquinazoline derivatives as methionine adenosyltransferase 2a inhibitors
JP2023532888A (ja) 2020-06-27 2023-08-01 クレセンタ バイオサイエンシズ 細胞代謝を調節する化合物の組成及び使用方法
US12138243B2 (en) 2021-12-31 2024-11-12 Crescenta Biosciences Antiviral use of FABP4 modulating compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4020866B1 (pt) * 1963-12-18 1965-09-16
US3509141A (en) 1966-09-15 1970-04-28 Ciba Geigy Corp 2-amino-quinazolines
JPS5323997A (en) 1976-08-16 1978-03-06 Sumitomo Chem Co Ltd Imidazoquinazoline derivatives and their preparation
JPS5398997A (en) 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation
US4282361A (en) * 1978-03-16 1981-08-04 Massachusetts Institute Of Technology Synthesis for 7-alkylamino-3-methylpyrazolo [4,3-d]pyrimidines
FR2514765A1 (fr) 1981-10-21 1983-04-22 Sanofi Sa Nouveaux derives de la phenyl-4 quinazoline actifs sur le systeme nerveux central
US4502880A (en) * 1983-02-03 1985-03-05 E. I. Du Pont De Nemours And Company 4-Pyridinium quinazoline derivatives
JPS62145073A (ja) 1985-12-19 1987-06-29 Dainippon Pharmaceut Co Ltd キナゾリン査導体
JPH06192099A (ja) * 1992-10-07 1994-07-12 Sumitomo Pharmaceut Co Ltd 腫瘍壊死因子産生阻害剤
WO1994007498A1 (fr) * 1992-10-07 1994-04-14 Sumitomo Pharmaceuticals Company, Limited Composition pharmaceutique utilisee pour inhiber la production des facteurs de necrose tumorale
JP2002522072A (ja) 1998-08-12 2002-07-23 マキシジェン， インコーポレイテッド 工業用化学薬品の製造のためのモノオキシゲナーゼ遺伝子のｄｎａシャッフリング。
US20040117871A1 (en) 2000-11-25 2004-06-17 Peter Meyer Plant growth regulation
JP4161597B2 (ja) 2001-03-15 2008-10-08 住友化学株式会社 サイトカイニン受容体に対するアゴニスト活性の分析方法
US7741049B2 (en) * 2001-03-15 2010-06-22 Sumitomo Chemical Company, Limited Analysis of agonist-activity and antagonist-activity to cytokinin receptor
DE10154075A1 (de) 2001-11-02 2003-05-15 Bayer Cropscience Ag Substituierte Pyrimidine
EP1667520A4 (en) 2003-08-22 2010-05-19 Stoller Ets PROCESS FOR IMPROVING GROWTH AND EARNINGS OF PLANTS BY REGULATING PLANT HORMONE MIRRORS, RELATIONSHIPS AND / OR COFECTORS
JP2007510642A (ja) 2003-11-03 2007-04-26 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 中枢神経系障害の治療のための新規ノルエピネフリン再取込み阻害薬

Also Published As

Publication number Publication date
RU2009123470A (ru) 2010-12-27
EP2100507A4 (en) 2009-12-23
CN101588716A (zh) 2009-11-25
CN101588716B (zh) 2014-03-05
US20100056377A1 (en) 2010-03-04
AU2007322610A1 (en) 2008-05-29
WO2008062907A1 (fr) 2008-05-29
KR20090091721A (ko) 2009-08-28
BRPI0719111A2 (pt) 2013-12-10
CA2669275C (en) 2015-02-24
EP2100507B1 (en) 2015-02-25
EP2100507A1 (en) 2009-09-16
KR20140054433A (ko) 2014-05-08
ES2532277T3 (es) 2015-03-25
US8722580B2 (en) 2014-05-13
CA2669275A1 (en) 2008-05-29
RU2477046C2 (ru) 2013-03-10
KR101486090B1 (ko) 2015-01-23
PL2100507T3 (pl) 2015-07-31

Similar Documents

Publication Publication Date Title
Linares et al. Effect of heat waves on morbidity and mortality due to Parkinson's disease in Madrid: a time-series analysis
Zhao et al. Grazing intensity influence soil microbial communities and their implications for soil respiration
Purser et al. An improved titration model reducing over estimation of total volatile fatty acids in anaerobic digestion of energy crop, animal slurry and food waste
Li Analysis of some enzymes activities of hydrogen sulfide metabolism in plants
Xiao-Ying et al. Impacts of climate change on forest ecosystems in Northeast China
BRPI0719111A8 (pt) agente para inibir a sinalização de citocinina
Zhao et al. Temporal variations of reference evapotranspiration and its sensitivity to meteorological factors in Heihe River Basin, China
BRPI1011617A2 (pt) composição, e, métodos para aprimorar a eficácia de um regulador de crescimento de planta, e para regular crescimento de planta
BR112012018294A2 (pt) método para detectar dióxido de carbono e sulfeto de hidrogênio em um ambiente de furo abaixo, e, aparelho de ferramenta de furo abaixop para detectar o dióxido de carbono e o sulfeto de hidrogênio.
BR112017007962A2 (pt) método implementado por computador, aparelho, mídia de armazenamento, programa de computador, kit, e, uso do kit
Yang et al. Genetic diversity and population structure of the endangered medicinal plant Phellodendron amurense in China revealed by SSR markers
Song et al. Effects of temperature, glucose and inorganic nitrogen inputs on carbon mineralization in a Tibetan alpine meadow soil
Rotundo et al. Response of maize photosynthesis to high temperature: Implications for modeling the impact of global warming
BRPI0600157A (pt) método para tratar uma planta, colheita, e, composição lìquida adequada para tratar plantas
BRPI0600359A (pt) método e meio legìvel por computador para proporcionar indicadores de desempenho chave acionados por planilha
BR112014031934A8 (pt) Método com base em euglobulina para determinar a atividade biológica de defibrotide
Eleftheriadis et al. Soil microbiological properties affected by land use, management, and time since deforestations and crop establishment
BRPI0514151A (pt) método e sistema para reduzir a adesão de depósitos indesejáveis em reatores de polimerização
BR112016027916A2 (pt) aperfeiçoamentos no uso de plataformas de cultura de sangue para testes de esterilidade comercial
BR112012008086A2 (pt) aparelho e método de análise de desgaste porca da haste de válvula.
Rockett et al. Phenotypic analysis of heat stress in Holsteins using test-day production records and NASA POWER meteorological data
BR112022014880A2 (pt) Controle de fábrica baseado em risco
Štepec et al. Fluorine in vegetation due to an uncontrolled release of gaseous fluorides from a glassworks: A case study of measurement uncertainty, dispersion pattern and compliance with regulation
BR112016007902A2 (pt) rnas não codificantes regulatórios como determinantes de macho-esterilidade em gramas e outras plantas monocotiledôneas
BRPI0812352A8 (pt) Agente promotor do crescimento de planta, fertilizante, e, agente promotor da germinação.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 13A ANUIDADE.

B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements